IMCR peer analysis
Immunocore (IMCR) against its competitors: price, today's move, 1-year return and market value side by side.
IMCR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BNTX BioNTech | $87.00 | 1.33% | -16.22% | $21.29B |
| CGEN Compugen | $1.92 | -5.42% | 17.07% | $181.88M |
| IBRX ImmunityBio | $8.59 | 7.29% | 278.60% | $8.49B |
| IMMP Immutep | $2.69 | -8.81% | -92.59% | $19.82M |
| IMTX Immatics | $6.36 | 2.91% | -30.65% | – |
| IPHA Innate Pharma | $1.40 | -1.75% | -32.37% | $156.38M |
| JANX Janux | $17.63 | 9.78% | -39.94% | – |
| MGNX MacroGenics | $2.33 | 4.95% | 59.72% | $141.41M |
| RCUS Arcus Biosciences | $18.28 | 3.34% | -9.27% | $2.55B |
| XNCR Xencor | $35.82 | 5.20% | 141.27% | $2.56B |
| IMCR Immunocore | $30.99 | 9.12% | -2.73% | – |
- IMCR's peers: BNTX (BioNTech), CGEN (Compugen), IBRX (ImmunityBio), IMMP (Immutep), IMTX (Immatics), IPHA (Innate Pharma), JANX (Janux), MGNX (MacroGenics).
Updated 2026-11-07 11:56 UTC